SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-011793
Filing Date
2024-08-12
Accepted
2024-08-12 07:05:55
Documents
16
Period of Report
2024-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adap-20240812x8k.htm   iXBRL 8-K 35461
2 EX-99.1 adap-20240812xex99d1.htm EX-99.1 323473
3 GRAPHIC adap-20240812xex99d1001.jpg GRAPHIC 10901
4 GRAPHIC adap-20240812xex99d1002.jpg GRAPHIC 4097
  Complete submission text file 0001558370-24-011793.txt   521894

Data Files

Seq Description Document Type Size
5 EX-101.SCH adap-20240812.xsd EX-101.SCH 3502
6 EX-101.LAB adap-20240812_lab.xml EX-101.LAB 15970
7 EX-101.PRE adap-20240812_pre.xml EX-101.PRE 10789
18 EXTRACTED XBRL INSTANCE DOCUMENT adap-20240812x8k_htm.xml XML 4916
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 241194710
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)